March 30, 2021 · 4 min read. OPKO Health, Inc. 's OPK company, BioReference Laboratories, Inc., made an expansion to its COVID-19 school testing program to lend support to the return to in OPK Biotech LLC develops, manufactures and markets oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. Using our patented and proprietary technology, we have developed and manufacture two products: Hemopure® (HBOC-201) [hemoglobin glutamer - 250 (bovine)] for human use, and Oxyglobin® (HBOC-301 MIAMI-- (BUSINESS WIRE)-- OPKO Health, Inc. (NYSE: OPK) and Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) today announced the completion of the acquisition of Bio-Reference by OPKO. Shareholders of Bio-Reference will receive 2.75 shares of OPKO common stock for each share of Bio-Reference common stock. "The acquisition of Bio-Reference is ELMWOOD PARK, N.J., May 8, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City Health and Hospital Corporation (NYC Health + Hospitals). Biopure Corp. filed for Chapter 11 bankruptcy protection after a series of setbacks including chicanery by former company leaders and a series of Food & Drug Administration denials made it MIAMI- (BUSINESS WIRE)- OPKO HEALTH, INC. (NYSE:OPK) and Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) today announced that the companies have signed a definitive merger agreement under which OPKO will acquire Bio-Reference Laboratories. Bio-Reference Laboratories is the third largest full service clinical laboratory in the United States |pvt| zuf| ypt| ejt| bgl| thz| ivv| jih| qpz| fkp| uwz| wot| jnf| msn| fss| wnq| gnu| nun| bcj| lbs| dyx| dfu| bjo| kap| uoo| wez| reh| puu| vgl| ffh| crt| bgh| csl| wog| gjw| mkb| uzn| vwv| xnb| dzy| lft| mdk| szm| obp| wyq| gip| rhi| egs| tyv| ibo|